Bioo Scientific

Bioo Scientific company information, Employees & Contact Information

Explore related pages

Related company profiles:

.

Company Details

Employees
18
Address
Global, Global,oo
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
New York.
HQ
Global
Looking for a particular Bioo Scientific employee's phone or email?

Bioo Scientific Questions

News

GSK pens $745M deal for phase 1 drug that hits sweet spots of COPD, oligonucleotides - Fierce Biotech

GSK pens $745M deal for phase 1 drug that hits sweet spots of COPD, oligonucleotides Fierce Biotech

GSK pens $357M pact with French biotech for prostate cancer ADC - Fierce Biotech

GSK pens $357M pact with French biotech for prostate cancer ADC Fierce Biotech

MapLight goes public via $250M IPO to fund Cobenfy competitor - Fierce Biotech

MapLight goes public via $250M IPO to fund Cobenfy competitor Fierce Biotech

Intellia pauses phase 3 CRISPR trials after patient is hospitalized - Fierce Biotech

Intellia pauses phase 3 CRISPR trials after patient is hospitalized Fierce Biotech

Novartis goes big for neuroscience with $12B deal for late-stage dystrophy biotech Avidity - Fierce Biotech

Novartis goes big for neuroscience with $12B deal for late-stage dystrophy biotech Avidity Fierce Biotech

Kite puts $1.6B on the line to pair up with China's Pregene for another in vivo CAR-T deal - Fierce Biotech

Kite puts $1.6B on the line to pair up with China's Pregene for another in vivo CAR-T deal Fierce Biotech

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech

BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence Fierce Biotech

Langer family RNA biotech Soufflé rises with $200M and Big Pharma partners - Fierce Biotech

Langer family RNA biotech Soufflé rises with $200M and Big Pharma partners Fierce Biotech

Eli Lilly and Nvidia team up to build 'most powerful' supercomputer in pharma - Fierce Biotech

Eli Lilly and Nvidia team up to build 'most powerful' supercomputer in pharma Fierce Biotech

Edesa claims survival data win for phase 3 respiratory failure trial - Fierce Biotech

Edesa claims survival data win for phase 3 respiratory failure trial Fierce Biotech

WuXi AppTec sharpens focus by selling off China-based clinical research units - Fierce Biotech

WuXi AppTec sharpens focus by selling off China-based clinical research units Fierce Biotech

Aldeyra shuffles RASP pack, dropping and swapping assets in response to data - Fierce Biotech

Aldeyra shuffles RASP pack, dropping and swapping assets in response to data Fierce Biotech

Labcorp posts solid Q3 results but trims full-year revenue forecast - Fierce Biotech

Labcorp posts solid Q3 results but trims full-year revenue forecast Fierce Biotech

AbbVie, Regeneron and Sanofi help fund $80M series A round for Tregs specialist Zag Bio - Fierce Biotech

AbbVie, Regeneron and Sanofi help fund $80M series A round for Tregs specialist Zag Bio Fierce Biotech

Convatec report finds 'widespread social stigma' tied to chronic conditions - Fierce Biotech

Convatec report finds 'widespread social stigma' tied to chronic conditions Fierce Biotech

Lonza to buy rapid microbial testing firm Redberry SAS - Fierce Biotech

Lonza to buy rapid microbial testing firm Redberry SAS Fierce Biotech

Incyte scraps BET inhibitor against backdrop of safety concerns for the drug class - Fierce Biotech

Incyte scraps BET inhibitor against backdrop of safety concerns for the drug class Fierce Biotech

Jupiter Endovascular's Vertex TFX catheter platform study shows positive results - Fierce Biotech

Jupiter Endovascular's Vertex TFX catheter platform study shows positive results Fierce Biotech

2025 M&A up in value and deal count after year of 'conservatism and recovery': Leerink Partners - Fierce Biotech

2025 M&A up in value and deal count after year of 'conservatism and recovery': Leerink Partners Fierce Biotech

De-Risking Clinical Development: Strategic Multipliers in Global Trials - Fierce Biotech

De-Risking Clinical Development: Strategic Multipliers in Global Trials Fierce Biotech

BridgeBio aces phase 3 rare disease test, clearing path to FDA - Fierce Biotech

BridgeBio aces phase 3 rare disease test, clearing path to FDA Fierce Biotech

Zenas' autoimmune drug prompts 95% reduction in new brain lesions in phase 2 MS study - Fierce Biotech

Zenas' autoimmune drug prompts 95% reduction in new brain lesions in phase 2 MS study Fierce Biotech

Hemab, working to build 'ultimate clotting company,' raises $157M series C for bleeding disorder ambitions - Fierce Biotech

Hemab, working to build 'ultimate clotting company,' raises $157M series C for bleeding disorder ambitions Fierce Biotech

Lilly buys cash-strapped Adverum for eye disease gene therapy - Fierce Biotech

Lilly buys cash-strapped Adverum for eye disease gene therapy Fierce Biotech

Redefining Biotech: How AI and Real-World Data Power Patient-Centered Progress - Fierce Biotech

Redefining Biotech: How AI and Real-World Data Power Patient-Centered Progress Fierce Biotech

Ignota buys Kronos' pipeline, igniting 2nd chance salvo to rescue shelved programs - Fierce Biotech

Ignota buys Kronos' pipeline, igniting 2nd chance salvo to rescue shelved programs Fierce Biotech

Novo shutters cell therapy unit, ending work on potential Type 1 diabetes 'cure' - Fierce Biotech

Novo shutters cell therapy unit, ending work on potential Type 1 diabetes 'cure' Fierce Biotech

After high-profile FDA exit, Peter Marks lands at Eli Lilly - Fierce Biotech

After high-profile FDA exit, Peter Marks lands at Eli Lilly Fierce Biotech

Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight - Fierce Biotech

Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight Fierce Biotech

Sanofi inks pact with Canadian tech company to bring AI to R&D - Fierce Biotech

Sanofi inks pact with Canadian tech company to bring AI to R&D Fierce Biotech

Flagship taps IQVIA as biotech support for company fleet - Fierce Biotech

Flagship taps IQVIA as biotech support for company fleet Fierce Biotech

UPDATED: Takeda lays off 137 US staff as part of retreat from cell therapy - Fierce Biotech

UPDATED: Takeda lays off 137 US staff as part of retreat from cell therapy Fierce Biotech

After a 'complete standstill,' private biotech market reaches new normal, investor says - Fierce Biotech

After a 'complete standstill,' private biotech market reaches new normal, investor says Fierce Biotech

James Mackay is tending to 'unfinished business' with new gout biotech and $205M fundraise - Fierce Biotech

James Mackay is tending to 'unfinished business' with new gout biotech and $205M fundraise Fierce Biotech

Big Pharma-backed Rome Therapeutics nears end of road with planned layoffs and strategic review - Fierce Biotech

Big Pharma-backed Rome Therapeutics nears end of road with planned layoffs and strategic review Fierce Biotech

Introducing Fierce Biotech's 2025 Fierce 15 - Fierce Biotech

Introducing Fierce Biotech's 2025 Fierce 15 Fierce Biotech

Trump admin mulls 'severe restrictions' on US pharmas licensing Chinese meds: NYT - Fierce Biotech

Trump admin mulls 'severe restrictions' on US pharmas licensing Chinese meds: NYT Fierce Biotech

US may be denying R&D grants for biotechs based on international investor links - Fierce Biotech

US may be denying R&D grants for biotechs based on international investor links Fierce Biotech

Novo Nordisk looks to next generation of obesity, diabetes drugs with $550M Replicate research deal - Fierce Biotech

Novo Nordisk looks to next generation of obesity, diabetes drugs with $550M Replicate research deal Fierce Biotech

Eli Lilly reconsiders UK biotech incubator, pauses buildout - Fierce Biotech

Eli Lilly reconsiders UK biotech incubator, pauses buildout Fierce Biotech

Genentech scraps $2B deal with cell therapy biotech - Fierce Biotech

Genentech scraps $2B deal with cell therapy biotech Fierce Biotech

Adaptimmune sells 4 cell therapies to pharma for $55M, plans layoffs - Fierce Biotech

Adaptimmune sells 4 cell therapies to pharma for $55M, plans layoffs Fierce Biotech

China biotechs ‘reshaping’ US biopharma as outlicensing deals rise 11%: Jefferies report - Fierce Biotech

China biotechs ‘reshaping’ US biopharma as outlicensing deals rise 11%: Jefferies report Fierce Biotech

Regeneron reports key phase 3 win in myasthenia gravis, gears up for FDA filing - Fierce Biotech

Regeneron reports key phase 3 win in myasthenia gravis, gears up for FDA filing Fierce Biotech

Sitala, backed by Forbion and OrbiMed, seals $670M deal for Fosun immune disease drug - Fierce Biotech

Sitala, backed by Forbion and OrbiMed, seals $670M deal for Fosun immune disease drug Fierce Biotech

Amgen to build $600M R&D site, hire hundreds in California - Fierce Biotech

Amgen to build $600M R&D site, hire hundreds in California Fierce Biotech

CSL to lay off up to 15% of workforce, cut R&D costs and spin out vaccine unit - Fierce Biotech

CSL to lay off up to 15% of workforce, cut R&D costs and spin out vaccine unit Fierce Biotech

Trinity Biotech reports its 15-day CGM works without fingersticks - Fierce Biotech

Trinity Biotech reports its 15-day CGM works without fingersticks Fierce Biotech

Ipsen hands back Sutro's ROR1 ADC at center of $875M deal - Fierce Biotech

Ipsen hands back Sutro's ROR1 ADC at center of $875M deal Fierce Biotech

Biopharma layoffs for first half of the year jump 32% YOY - Fierce Biotech

Biopharma layoffs for first half of the year jump 32% YOY Fierce Biotech

Xoma adds fading Mural Oncology to portfolio of struggling biotechs - Fierce Biotech

Xoma adds fading Mural Oncology to portfolio of struggling biotechs Fierce Biotech

Bayer picks Kumquat for KRAS collaboration, with $1.3B on offer if pact bears fruit - Fierce Biotech

Bayer picks Kumquat for KRAS collaboration, with $1.3B on offer if pact bears fruit Fierce Biotech

VantAI plays matchmaker for Halda's 'hold-and-kill' drugs in $1B deal - Fierce Biotech

VantAI plays matchmaker for Halda's 'hold-and-kill' drugs in $1B deal Fierce Biotech

Cell therapy biotech Adicet turns to autoimmune, shedding a phase 1 asset and 30% of staffers - Fierce Biotech

Cell therapy biotech Adicet turns to autoimmune, shedding a phase 1 asset and 30% of staffers Fierce Biotech

Enveda harvests another $150M to advance nature-inspired drugs - Fierce Biotech

Enveda harvests another $150M to advance nature-inspired drugs Fierce Biotech

FDA moves to publish drug rejection letters in real time, releases new batch including Replimune's high-profile snub - Fierce Biotech

FDA moves to publish drug rejection letters in real time, releases new batch including Replimune's high-profile snub Fierce Biotech

Taxes, tariffs and interest rates hold key to biotech's future amid uncertain outlook: EY - Fierce Biotech

Taxes, tariffs and interest rates hold key to biotech's future amid uncertain outlook: EY Fierce Biotech

China proposes shorter clinical trial reviews in efforts to accelerate drug development - Fierce Biotech

China proposes shorter clinical trial reviews in efforts to accelerate drug development Fierce Biotech

Boehringer pens $327M pact with Palatin to develop new therapies for diabetic retinopathy - Fierce Biotech

Boehringer pens $327M pact with Palatin to develop new therapies for diabetic retinopathy Fierce Biotech

UPDATE: Analyst questions impact of FDA's rare disease pathway proposal - Fierce Biotech

UPDATE: Analyst questions impact of FDA's rare disease pathway proposal Fierce Biotech

Vedanta's live bacteria cocktail fails to reduce ulcerative colitis severity in phase 2 trial - Fierce Biotech

Vedanta's live bacteria cocktail fails to reduce ulcerative colitis severity in phase 2 trial Fierce Biotech

Merck executes its own Brexit, moving all R&D operations out of UK - Fierce Biotech

Merck executes its own Brexit, moving all R&D operations out of UK Fierce Biotech

ARPA-H data chief departs over disagreement with mRNA vaccine rollback - Fierce Biotech

ARPA-H data chief departs over disagreement with mRNA vaccine rollback Fierce Biotech

Lilly rounds out oral GLP-1 approval bid with phase 3 obesity win for patients with diabetes - Fierce Biotech

Lilly rounds out oral GLP-1 approval bid with phase 3 obesity win for patients with diabetes Fierce Biotech

Gilead culls Novo-partnered MASH candidate and 2 cancer assets - Fierce Biotech

Gilead culls Novo-partnered MASH candidate and 2 cancer assets Fierce Biotech

Merck KGaA swoops into Skyhawk neurological disease pact worth up to $2B - Fierce Biotech

Merck KGaA swoops into Skyhawk neurological disease pact worth up to $2B Fierce Biotech

'America-first resurgence': Amid market correction, biotech nears new era, PitchBook says - Fierce Biotech

'America-first resurgence': Amid market correction, biotech nears new era, PitchBook says Fierce Biotech

2025 Fierce CRO Awards - Fierce Biotech

2025 Fierce CRO Awards Fierce Biotech

Sanofi-backed SpliceBio secures $135M series B for eye disease gene therapy trials - Fierce Biotech

Sanofi-backed SpliceBio secures $135M series B for eye disease gene therapy trials Fierce Biotech

Cell therapy biotech shares first clinical data for in vivo CAR-T that attracted $1B AstraZeneca acquisition - Fierce Biotech

Cell therapy biotech shares first clinical data for in vivo CAR-T that attracted $1B AstraZeneca acquisition Fierce Biotech

Lilly opens Gate to new small-molecule drug class with $856M biobucks deal - Fierce Biotech

Lilly opens Gate to new small-molecule drug class with $856M biobucks deal Fierce Biotech

Sanofi phase 3 eczema win falls short of analyst expectations - Fierce Biotech

Sanofi phase 3 eczema win falls short of analyst expectations Fierce Biotech

Medtronic expands board to chase M&A, efficiencies as activist investor takes stake - Fierce Biotech

Medtronic expands board to chase M&A, efficiencies as activist investor takes stake Fierce Biotech

Avantor comes under pressure from activist investor Engine Capital - Fierce Biotech

Avantor comes under pressure from activist investor Engine Capital Fierce Biotech

UPDATED: Analysts demand transparency after Sarepta's roundabout disclosure of 3rd patient death - Fierce Biotech

UPDATED: Analysts demand transparency after Sarepta's roundabout disclosure of 3rd patient death Fierce Biotech

TCG Labs Soleil raises $400M for single-asset biotechs, expands R&D footprint to China - Fierce Biotech

TCG Labs Soleil raises $400M for single-asset biotechs, expands R&D footprint to China Fierce Biotech

Pfizer expands AI-powered small-molecule discovery collab with XtalPi - Fierce Biotech

Pfizer expands AI-powered small-molecule discovery collab with XtalPi Fierce Biotech

Bristol Myers inks $11B BioNTech deal to join bispecific gold rush, leaping ahead of Merck and Pfizer - Fierce Biotech

Bristol Myers inks $11B BioNTech deal to join bispecific gold rush, leaping ahead of Merck and Pfizer Fierce Biotech

Eli Lilly pays $1B upfront to buy gene editing partner Verve Therapeutics - Fierce Biotech

Eli Lilly pays $1B upfront to buy gene editing partner Verve Therapeutics Fierce Biotech

GSK strengthens COPD offering via $12B biobucks, 12-program deal with China's Hengrui Pharma - Fierce Biotech

GSK strengthens COPD offering via $12B biobucks, 12-program deal with China's Hengrui Pharma Fierce Biotech

AbbVie reels in Capstan in $2.1B buyout, charting course for in vivo CAR-T market - Fierce Biotech

AbbVie reels in Capstan in $2.1B buyout, charting course for in vivo CAR-T market Fierce Biotech

Fierce Biotech Layoff Tracker 2025: Alector halves staff; Galapagos axes cell therapy unit - Fierce Biotech

Fierce Biotech Layoff Tracker 2025: Alector halves staff; Galapagos axes cell therapy unit Fierce Biotech

FDA misses IND deadline for Coya's ALS asset, cites lack of resources - Fierce Biotech

FDA misses IND deadline for Coya's ALS asset, cites lack of resources Fierce Biotech

Congressional commission urges $15B, more action to maintain US biotech advantage over China - Fierce Biotech

Congressional commission urges $15B, more action to maintain US biotech advantage over China Fierce Biotech

Alphabet's Calico stitches $596M deal for Mabwell's anti-aging asset - Fierce Biotech

Alphabet's Calico stitches $596M deal for Mabwell's anti-aging asset Fierce Biotech

Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication - Fierce Biotech

Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication Fierce Biotech

Aiming to disrupt the cardiovascular space, 2 industry vets unveil Boston biotech with preventive RNAi asset - Fierce Biotech

Aiming to disrupt the cardiovascular space, 2 industry vets unveil Boston biotech with preventive RNAi asset Fierce Biotech

Roche’s Chugai inks $250M Gero deal to access age-related disease targets - Fierce Biotech

Roche’s Chugai inks $250M Gero deal to access age-related disease targets Fierce Biotech

RA Capital's biotech incubator lays off staffers: Stat - Fierce Biotech

RA Capital's biotech incubator lays off staffers: Stat Fierce Biotech

Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug - Fierce Biotech

Pathos AI secures $365M series D to fund trial of Novo Nordisk solid tumor drug Fierce Biotech

J&J ties early-stage lymphoma CAR-T to 100% response rate in 10 patients - Fierce Biotech

J&J ties early-stage lymphoma CAR-T to 100% response rate in 10 patients Fierce Biotech

Months after layoffs, AbbVie-partnered protein degrader specialist Plexium raises $60M - Fierce Biotech

Months after layoffs, AbbVie-partnered protein degrader specialist Plexium raises $60M Fierce Biotech

The top 10 pharma R&D budgets for 2024 - Fierce Biotech

The top 10 pharma R&D budgets for 2024 Fierce Biotech

Eli Lilly enlists Camurus to help unlock long-acting obesity market in deal worth up to $870M - Fierce Biotech

Eli Lilly enlists Camurus to help unlock long-acting obesity market in deal worth up to $870M Fierce Biotech

Several months after Exscientia merger, AI biotech outfit Recursion reworks pipeline - Fierce Biotech

Several months after Exscientia merger, AI biotech outfit Recursion reworks pipeline Fierce Biotech

Verve's 2nd swing at PCSK9 editing yields clean safety profile, teeing up Lilly opt-in decision - Fierce Biotech

Verve's 2nd swing at PCSK9 editing yields clean safety profile, teeing up Lilly opt-in decision Fierce Biotech

ProKidney’s CKD cell therapy scores win in one half of phase 2 trial, falls short on other - Fierce Biotech

ProKidney’s CKD cell therapy scores win in one half of phase 2 trial, falls short on other Fierce Biotech

Anti-aging biotech NewLimit raises $130M to push liver reprogramming med into clinic - Fierce Biotech

Anti-aging biotech NewLimit raises $130M to push liver reprogramming med into clinic Fierce Biotech

Fierce Biotech Fundraising Tracker '25: Hemab closes $157M series C; Electra shines with $183M - Fierce Biotech

Fierce Biotech Fundraising Tracker '25: Hemab closes $157M series C; Electra shines with $183M Fierce Biotech

Kymera suffers Sanofi setback but secures $750M Gilead deal - Fierce Biotech

Kymera suffers Sanofi setback but secures $750M Gilead deal Fierce Biotech

Top Bioo Scientific Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant